Prognosticators of Long-Term Outcomes of TNM Stage II Colorectal Cancer: Molecular Patterns or Clinicopathological Features
- 5 Downloads
Patients with stage II colorectal cancer (CRC) have a higher risk of recurrence when they have certain risk factors, including clinical and pathological patterns. However, as the prognostic role of molecular patterns for stage II disease is still unclear, this study aimed to investigate it.
A total of 509 patients with stage II CRC were enrolled, and all clinical, pathological, and molecular data were collected. Molecular patterns included microsatellite instability (MSI); elevated microsatellite alterations at selected tetranucleotides (EMAST) status; and expression of RAS/RAF genes, genes of the APC pathway, and other gene mutations. The endpoints were oncological outcomes, including overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), local recurrence (LR), and distant recurrence (DR). Cox regression analysis was used.
Numerous molecular patterns influenced the oncological outcomes on univariate analysis, but no variable reached significance in LR. On multivariate analysis, a mucinous component (MC) > 50% (P < 0.01) was significant for OS and CSS. Lymphovascular invasion (LVI; P< 0.01), MC > 50% (P < 0.01), and EMAST-H (P = 0.02) significantly influenced DFS, whereas LVI (P < 0.01), MC > 50% (P < 0.01), and TP53 mutation (P = 0.02) were significant for DR.
In this study, MSI, EMAST, and RAS/RAF alterations did not influence the oncological outcomes. Overall, LVI and MC were two significant prognostic factors for DFS and DR. Thus, the histopathology, rather than the genes, plays a major role in the prognosis of patients with stage II CRC.
Tai-Chuan Kuan and Shih-Ching Chang drafted/revised this article and analyzed the data. Shih-Ching Chang was involved in conception and design. Jen-Kou Lin, Tzu-Chen Lin, Shung-Haur Yang, Jeng-Kae Jiang, Wei-Shone Chen, Huann-Sheng Wang, Yuan-Tzu Lan, Chun-Chi Lin, Hung-Hsin Lin, and Sheng-Chieh Huang contributed to acquisition of data.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
- 1.The Department of Health t E Y (2013) The Department of Health. Healthy statistics: Cancer Registry Annual Report in Taiwan Area, Taiwan, R.O.CGoogle Scholar
- 4.Chang SC, Lin JK, Lin TC et al (2005) Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. Int J Oncol 26(1):65–75Google Scholar
- 13.NCCN Clinical Practice Guideline in Oncology Colon Cancer, (2017).Google Scholar
- 15.Perucho M (1999) Correspondence re: C.R. Boland et al., A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58: 5248–5257, 1998. Cancer Res 59(1):249–256Google Scholar
- 20.Johnson SM, Gulhati P, Rampy BA, et al (2010) Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg 210(5): 767–776, 776–768.Google Scholar
- 21.Danielsen SA, Eide PW, Nesbakken A et al (2015) Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta 1855(1):104–121Google Scholar
- 28.Yamada K, Kanazawa S, Koike J et al (2010) Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan. Oncol Rep 23(2):551–561Google Scholar
- 41.Masuda T, Hayashi N, Kuroda Y, et al (2017) MicroRNAs as Biomarkers in Colorectal Cancer. Cancers (Basel) 9(9).Google Scholar
- 43.Rozek LS, Schmit SL, Greenson JK, et al (2016) Tumor-infiltrating lymphocytes, crohn's-like lymphoid reaction, and survival from colorectal cancer. J Natl Cancer Inst 108(8).Google Scholar
- 44.Ko YS, Pyo JS (2019) Clinicopathological significance and prognostic role of tumor-infiltrating lymphocytes in colorectal cancer. Int J Biol Markers: 1724600818817320.Google Scholar